stockportfolio.pro
INSM vs ZBH: Which Stock Is the Better Buy?
Insmed Incorporated and Zimmer Biomet Holdings, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
AI verdict — INSM vs ZBH, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| Insmed Incorporated (INSM) | Zimmer Biomet Holdings, Inc. (ZBH) | |
|---|---|---|
| Market cap | $20.9B | $16.9B |
| Revenue (latest FY) | $606.42M | $8.23B |
| Net income (latest FY) | $-1.28B | $705.10M |
| Revenue growth (5y CAGR) | 29.8% | 6.1% |
| Net margin | -210.5% | 8.6% |
| Return on equity | -172.8% | 5.6% |
| P/E ratio | — | 22.7 |
| Dividend yield | — | 1.1% |
| Profitable years (of last 10) | 0 | 8 |
| Positive free cash flow | No | Yes |
See the full INSM vs ZBH breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open INSM's full financials → Open ZBH's full financials →More comparisons
Frequently asked questions
Which is bigger, INSM or ZBH?
Insmed Incorporated is larger by market capitalization — $20.9B versus $16.9B.
Which grows faster, INSM or ZBH?
Over the last five fiscal years, Insmed Incorporated grew revenue faster — 29.8%/yr versus 6.1%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.
Keep exploring
INSM fundamentals → · ZBH fundamentals → · All 1,500+ companies → · Free screener →